...
首页> 外文期刊>Vaccine >A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens
【24h】

A two-codon mutant of cholera toxin lacking ADP-ribosylating activity functions as an effective adjuvant for eliciting mucosal and systemic cellular immune responses to peptide antigens

机译:缺乏ADP-核糖基化活性的霍乱毒素的两个密码子突变体作为引发佐剂和全身细胞对肽抗原的免疫应答的有效佐剂

获取原文
获取原文并翻译 | 示例
           

摘要

Vaccination with peptide antigens is an effective strategy against mucosal viral infections. We tested a two-codon mutant of cholera toxin (CT-2*) lacking ADP-ribosylating activity and toxicity as a mucosal adjuvant for T cell epitope peptides for intranasal immunization of mice. Efficient induction of helper and cytotoxic T lymphocyte responses associated with TH1 cytokine production were observed in the systemic and mucosal compartments including nasal, gut, and vaginal associated lymphoid tissues. Single or multiple dosing with the peptide antigen and CT-2* induced strong memory immunity without tolerance. These results demonstrate CT-2* as a suitable mucosal adjuvant for priming antigen-specific cellular immune responses. Copyright 2004 Published by Elsevier Ltd.
机译:肽抗原疫苗接种是抵抗粘膜病毒感染的有效策略。我们测试了霍乱毒素(CT-2 *)的两密码子突变体,该突变体缺乏ADP-核糖基化活性和毒性,作为小鼠鼻内免疫T细胞表位肽的粘膜佐剂。在包括鼻,肠和阴道相关淋巴组织在内的全身和粘膜区室中观察到与TH1细胞因子产生相关的辅助诱导和细胞毒性T淋巴细胞反应的有效诱导。肽抗原和CT-2 *的单次或多次给药诱导了强大的记忆免疫力,而没有耐受性。这些结果证明CT-2 *是用于引发抗原特异性细胞免疫应答的合适粘膜佐剂。版权所有2004,由Elsevier Ltd.发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号